Saturday, September 30, 2023
HomeBusinessMerck in late-stage talks to acquire Prometheus Biosciences

Merck in late-stage talks to acquire Prometheus Biosciences


Related stories

Judge denies request to block

A pharmacist holds a bottle of the drug...

Melbourne’s Brand Whisperers: BrandVillage- Your Trusted Brand Designers

Branding is the fusion of creativity and strategy that...

Credit Suisse sheds nearly 13% of workforce By Reuters

© Reuters. The logo of Credit Suisse is...

Can China’s economy reverse a sluggish 2023 in the last quarter?

This photo taken on September 24, 2023, shows...

How to Select the Ideal SMS Verification Service for Your Business

SMS verification is an essential process that ensures users'...

© Reuters. FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly

(Reuters) -Merck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter.

A deal could be announced as soon as Sunday, the people quoted said, though cautioning the talks could still fall apart.

Prometheus, a clinical-stage biotechnology company specializing in therapeutic products for the treatment of immune-mediated diseases, had a market capitalization of $5.42 billion as of the close on Friday.

Merck has been looking for deals to protect itself from eventual revenue loss as its cancer immunotherapy Keytruda patents begin to expire toward the end of the decade.

Merck in February forecast 2023 earnings below Wall Street estimates and an expected steep decline in sales of its COVID-19 antiviral treatment.

Merck and Prometheus did not immediately respond to a Reuters request for comment.

Source link

Bellie Brown
Bellie Brown
Hi my lovely readers, I am Bellie brown editor and writer of I write blogs on various niches such as business, technology, lifestyle., health, entertainment, etc as well as manage the daily reports of the website. I am very addicted to my work which makes me keen on reading and writing on the very latest and trending topics. One can check my more writings by visiting

Latest stories